Furthermore, in vitro inhibition of this signaling pathway by either pharmacological or RNAi strategies rescues neurogenic impairments observed in the absence of PTPRD (Tomita et al., 2020), providing a direct link between PTPRD mutations and neurodevelopmental disorders. Here, PTPRD is linked to neurodevelopmental disorder.